Advertisement

Medicinal Chemistry Research

, Volume 28, Issue 1, pp 52–61 | Cite as

Study on synthesis and biological effects of a series of 3,4-dihydroisoquinoline-2(1H)-carboxamide derivatives

  • Zhi-Yang Fu
  • Qing-Hao Jin
  • Ya-Nan Xia
  • Hai-Ying JiangEmail author
  • Li-Ping GuanEmail author
Original Research
  • 39 Downloads

Abstract

In this paper, we have reported the synthesis and biological evaluation of nineteen (S)-N-substituted-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxamide derivatives as novel candidate antidepressant and anticonvulsant agents. Compounds 2h, 2k, 2r, and 2s exhibited better potent antidepressant activity and displayed the antidepressant effects in a dose-dependent manner from 10 to 30 mg/kg in the FST and TST. And, we found that the best antidepressant effect of compounds 2r and 2s are likely mediated by an increase in central nervous system 5-HT and NE. In addition, compounds 2r and 2s also exhibited the anticonvulsant activity against MES-induced seizures. Thus, compounds 2r and 2s may be a useful antidepressant adjunct therapy for treating depression in patients with epilepsy. In addition, compounds 2r and 2s showed the anti-inflammatory activity and the excellent analgesic activity. Several scholars have postulated the anti-inflammatory and analgesic effects of antidepressant drugs, suggesting that they may be possess a similar mechanism of action.

Keywords

Isoquinoline-2(1H)-carboxamide Synthesis Antidepressant Anticonvulsant Neurotransmitter 

Notes

Acknowledgements

This research was funded by the National Natural Science Foundation of China (No. 81560149) and 13th Five-Year Key Projects of Jilin Provincial Education Department of China (No. JJKH2016261H).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Bauman JN, Frederick KS, Sawant A, Walsky RL, Cox LM, Obach RS, Kalgutkar AS (2008) Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug. Drug Metab Dispos 36:1016–1029CrossRefGoogle Scholar
  2. Boufidou F, Nikolaou C (2016) Anti-inflammatory medication as adjunctive antidepressive treatment. Psychiatriki 27:106–117CrossRefGoogle Scholar
  3. Brajša K, Vujasinović I, Jelić D, Trzun M, Zlatar I, Karminski-Zamola G, Hranjec M (2016) Antitumor activity of amidino-substituted benzimidazole and benzimidazo[1,2-a]quinoline derivatives tested in 2D and 3D cell culture systems. J Enzym Inhib Med Chem 31:1139–1145CrossRefGoogle Scholar
  4. D’Angelo V, Tessari F, Bellagamba G, De Luca E, Cifelli R, Celia C, Primavera R, Di Francesco M, Paolino D, Di Marzio L, Locatelli M (2016) Microextraction by packed sorbent and HPLC-PDA quantification of multiple anti-inflammatory drugs and fluoroquinolones in human plasma and urine. J Enzym Inhib Med Chem 31(sup3):110–116CrossRefGoogle Scholar
  5. Deng XQ, Song MX, Zheng Y, Quan ZS (2014) Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones. Eur J Med Chem 73:217–224CrossRefGoogle Scholar
  6. Dhanda S, Sandhir R (2015) Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy. Behav Brain Res 286:222–235CrossRefGoogle Scholar
  7. Drinovac M, Wagner H, Agrawal N, Cock HR, Mitchell AJ, Von Oertzen TJ (2015) Screening for depression in epilepsy: a model of an enhanced screening tool. Epilepsy Behav 44:67–72CrossRefGoogle Scholar
  8. Fang FQ, Guo HS, Zhang J, Ban LY, Liu JW, Yu PY (2015) Anti-cancer effects of 2- oxoquinoline derivatives on the HCT116 and LoVo human colon cancer cell lines. Mol Med Rep 12:8062–8070CrossRefGoogle Scholar
  9. Franci G, Manfroni G, Cannalire R, Felicetti T, Tabarrini O, Salvato A, Barreca ML, Altucci L, Cecchetti V (2015) Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives. Cell Prolif 48:705–717CrossRefGoogle Scholar
  10. Gaidukevich SK, Mikulovich YL, Smirnova TG, Andreevskaya SN, Sorokoumova GM, Chernousova LN, Selishcheva AA, Shvets VI (2016) Antibacterial effects of liposomes containing phospholipid cardiolipin and fluoroquinolone levofloxacin on mycobacterium tuberculosis with extensive drug resistance. Bull Exp Biol Med 160:675–678CrossRefGoogle Scholar
  11. Guan LP, Zhao DH, Chang Y, Sun Y, Ding XL, Jiang JF (2013) Design, synthesis and antidepressant activity evaluation 2´-hydroxy-4´,6´-diisoprenyloxychalcone derivatives. Med Chem Res 22:5218–5226CrossRefGoogle Scholar
  12. Guan LP, Xia YN, Jin QH, Liu BY, Wang SH (2017) Synthesis, potential anti-inflammatory and analgesic activities study of (S)-N-substituted-1-phenyl-3,4-dihydroisoquinoline-2(1H)- carboxamides. Bioorg Med Chem Lett 27:3378–3381CrossRefGoogle Scholar
  13. Hao CW, Lai WS, Ho CT, Sheen LY (2013) Antidepressant-like effect of lemon essential oil is through a modulation in the levels of norepinephrine, dopamine, and serotonin in mice: Use of the tail suspension test. J Funct Foods 5:370–379CrossRefGoogle Scholar
  14. Ismail H, Dilshad E, Waheed MT, Mirza B (2017) Transformation of Lettuce with rol ABC Genes: extracts show enhanced antioxidant, analgesic, anti-inflammatory, antidepressant, and anticoagulant activities in rats. Appl Biochem Biotechnol 181:1179–1198CrossRefGoogle Scholar
  15. Jin HG, Zhou M, Jin QH, Liu BY, Guan LP (2017) Antidepressant-like effects of saringosterol, a sterol from Sargassum fusiforme by performing in vivo behavioral tests. Med Chem Res 26:909–915CrossRefGoogle Scholar
  16. Kumar S, Bawa S, Drabu S, Gupta H, Machwal L, Kumar R (2011) Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinolineamine derivatives. Eur J Med Chem 46:670–675CrossRefGoogle Scholar
  17. Liu Z, Sun C, Tao R, Xu X, Xu L, Cheng H, Wang Y, Zhang D (2016) Pyrroloquinoline quinone decelerates rheumatoid arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathways. Inflammation 39:248–256CrossRefGoogle Scholar
  18. McNamara JO (2011) Pharmacotherapy of the epilepsies. In: Brunton LL, Chabner BA, Knollmann BC (Eds.). Goodman & Gilman’s the phamacological basis of therapeutics, twelfth edn. McGraw-Hill, New York, NY, p 583–608Google Scholar
  19. Meyer C (2004) Depressive disorders were the fourth leading cause of global disease burden in the year 2000. Evid Based Ment Health 7:123–127CrossRefGoogle Scholar
  20. Naeem A, Badshah SL, Muska M, Ahmad N, Khan K (2016) The current case of quinolones: synthetic approaches and antibacterial activity. Molecules 21:268–287CrossRefGoogle Scholar
  21. Obaid A, Sandhya B, Suresh K (2013) Design, synthesis and evaluation of novel 2-piperidinyl quinoline chalcones/amines as potential antidepressant agents. Lett Drug Des Discov 10:75–85CrossRefGoogle Scholar
  22. Oshiro Y, Sakurai Y, Sato S (2000) 3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4-dihydro-5- methoxy-2(1H)-quinolinone and its derivatives. J Med Chem 43:177–189CrossRefGoogle Scholar
  23. Porsolt RD, Bertin A, Jalfre M (1997) Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn 229:327–336Google Scholar
  24. Porter RJ, Cereghino JJ, Gladding GD, Hessie BJ, Kupferberg HJ, Scoville B, White BG (1984) Antiepileptic drug development program. Cleve Clin Q 51:293–305CrossRefGoogle Scholar
  25. Schröder J, Brückner K, Fischer A, Lindenau M, Köther U, Vettorazzi E, Moritz S (2014) Efficacy of a psychological online intervention for depression in people with epilepsy: a randomized controlled trial. Epilepsia 55:2069–2076CrossRefGoogle Scholar
  26. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367–370CrossRefGoogle Scholar
  27. Sun XY, Zhang L, Wei CX, Piao HR, Quan ZS (2009) Design, synthesis of 8-alkoxy-5,6-dihydro- [1,2,4]triazino[4,3-a]quinolin-1-ones with anticonvulsantactivity. Eur J Med Chem 44:1265–1270CrossRefGoogle Scholar
  28. Sun XY, He XJ, Pan CY, Liu YP, Zou YP (2012) Synthesis and study of the antidepressant activity of novel 4,5-dihydro-7-alkoxy(phenoxy)-tetrazolo[1,5-a]quinoline derivatives. Med Chem Res 21:3692–3698CrossRefGoogle Scholar
  29. Uddin MMN, Kabir MSH, Hasan M, Al Mahmud Z, Alam Bhuiya NMM, Ahmed F, Hasan MR, Hosen MT, Alam MS (2018) Assenssment of the antioxidant, thrombolytic, analgesic, anti-inflammatory, antidepressant and anxiolytic activities of leaf extracts and fractions of Tetracera sarmentosa (L.) Vahl. J Basic Clin Physiol Pharmacol 29:81–93CrossRefGoogle Scholar
  30. Xu J, Xu H, Liu Y, He H, Li G (2015) Vanillin-induced amelioration of depression-like behaviors in rats by modulating monoamine neurotransmitters in the brain. Psychiatry Res 225:509–514CrossRefGoogle Scholar
  31. Zhen XH, Quan YC, Peng Z, Han Y, Zheng ZJ, Guan LP (2016) Design, synthesis, and potential antidepressant-like activity of 7-prenyloxy-2,3-dihydroflavanone derivatives. Chem Biol Drug Des 87:858–866CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Food and Pharmacy CollegeZhejiang Ocean UniversityZhouShanChina
  2. 2.Donghai Science and Technology CollegeZhejiang Ocean UniversityZhoushanChina
  3. 3.College of MedicineJiaxing UniversityJiaxingChina

Personalised recommendations